SlideShare uma empresa Scribd logo
1 de 53
Cognitive Changes after
 Breast Cancer and its
      Treatment
                 Fremonta Meyer, MD
 Department of Psychosocial Oncology and Palliative Care
             Dana-Farber Cancer Institute
                     June 6, 2012
Outline
   Impact

   Why focus on breast cancer?

   Research findings

   Interventions
What symptoms are you experiencing?
So…
   Is it real?

   What causes it?

   What can be done about it?
Patient Experiences
   “I have been so lost [while
    driving], I just pull over, and
    break down and start crying.
    Because it’s places I’ve been
    before and I know where I
    am going…”
   “I couldn’t remember if I
    looked at a stoplight. I felt
    like it was putting myself at
    risk.”
   “What I have to do
    sometimes is have my son
    come over and pay my bills.”*
                                      * Boykoff et al, J Cancer Surviv, 2009
Impact on Quality of Life
   Distress due to lack of acknowledgment by medical
    community

   Mixed reactions from family and friends

   Decline in job performance

   Avoidance of social occasions

   Depression and anxiety

            * Boykoff et al, J Cancer Surviv, 2009
Chemobrain can affect many areas of
       cognitive function
   Memory
   Attention/concentration
   Information processing speed
   Executive function
     Initiation
     Planning
     Organization
     Multi-tasking
     Response inhibition
Research shows that the majority of patients on
    chemotherapy experience cognitive side effects
   67% of patients reported experiencing memory and
    concentration problems during chemotherapy
   These problems were still present 6 months after completing
    chemotherapy
      Memory                                           Concentration



                            *Kohli et al, J Oncol
                            Practice, 2007
For most people, chemobrain
      gradually disappears over time
   17-34% of people continue to have problems
    after the end of chemotherapy

   Some neuroimaging studies show
    improvement/resolution of regional brain
    volume differences as of 3 years post-
    chemotherapy
                    *Inagaki et al, Cancer, 2007
Chemobrain leads to dysfunction of
 frontal-subcortical brain networks
Chemobrain is not the same as dementia

   Chemobrain is not a progressive condition
   Chemobrain does not increase risk for
    Alzheimer’s disease
   The cognitive findings in Alzheimer’s disease are
    different
     In Alzheimer’s, memory cues don’t help
     In chemobrain, memory cues help
*Ferguson et al, JCO, 2007
Why do we study breast cancer?
   Common cancer with largest population of
    survivors (23%; 2.6 million)

   Limited direct effects of cancer on brain other
    than chemotherapy

   Population allows chemotherapy vs non-
    chemotherapy study designs
Why don’t more oncologists study this?


   Oncology research tends to focus on clearly
    defined outcomes or “endpoints”
     Overall survival (OS)
     Progression-free survival (PS)




   What’s the “endpoint” for chemobrain?
Endpoints for chemobrain are controversial.

    Functional neuroimaging findings (fMRI)

    Neuropsychological tests
         May not reflect “real life”

    Self-reported cognitive problems
       May have other causes
       But, interestingly, seems to be most similar to fMRI
        results
Empathy for your oncologist
          and other physicians…
   It’s important to understand where your
    oncologist is coming from…

     The research on this topic is very confusing
     There aren’t yet any FDA approved treatments for
      chemobrain
     This makes it hard for them to know what to
      recommend!
Problems with the Older Research
   Cross-sectional studies
        Looking only at people who already completed cancer treatment

   Prospective studies without matched control groups
        Looking only at people who had cancer and received chemotherapy

   Not enough patients

   Multiple chemotherapy regimens

   Not controlling for hormonal therapies

   Not controlling for patients getting better at neuropsychological tests because they
    have practiced them (rather than their chemobrain actually improving)

   Excluding people with depression, anxiety, sleep problems
Summary of the better-quality research
          using neuropsychological testing
   8 prospective longitudinal studies with matched control
    +/- healthy control group*
       Acute declines in motor skills, processing speed,
        verbal/visual memory which improved over time
       Chemotherapy may have specific negative effect on verbal
        fluency
       Patients exposed to chemotherapy plus tamoxifen did
        worse at later timepoints than pts exposed to chemotherapy
        alone

       But: 3 studies did not show any cognitive impairment with
        standard-dose chemotherapy
        *Quesnel 2009, Schagen 2009, Tager 2010, Bender 2006, Collins 2009, Jenkins 2006,
        Mehlsen 2009, Ahles 2010
How would you design a
study, from your perspective
    as a cancer survivor?
Added Observations
   Some people with breast cancer (11-33%) have
    cognitive problems prior to receiving any
    chemotherapy at all*

     Anxiety
     Anesthesia from surgeries

     Something that the tumor directly causes –
      “paraneoplastic”

        *Ahles et al, Breast Cancer Res Treat, 2008
The dentate gyrus of the hippocampus is
involved in the formation of new memories
A Close-Up of the Dentate Gyrus
What chemotherapy regimens do most
      women receive for breast cancer?
   “AC” then “T”:

     A=adriamycin (doxorubicin)
     C=cyclophosphamide (Cytoxan)

     T=docetaxel (Taxotere)
What is the blood-brain barrier (BBB)?
   Microscopic objects (e.g. bacteria) can’t get in. Neither can
    hydrophilic molecules. But it doesn’t keep everything out…
   Cyclophosphamide (cytoxan) and 5-
    fluorouracil (often used in treatment for colon
    cancer) can cross the BBB.

   Doxorubicin and paclitaxel do not directly cross
    the BBB.
In mice, chemotherapy agents appear to result in reduced
   cell growth in the dentate gyrus of the hippocampus



                                              *Janelsins et al, Cancer
                                              Investigation, 2010
Take-Home Points
   Even chemotherapies that do not cross the BBB (such
    as doxorubicin and doxetaxel/paclitaxel) may result in
    decreased neurogenesis (growth of neurons)

   Growth factors may result in increased survival of
    neural cells
       IGF-1, BDNF, VEGF, FGF

   So, if we can confirm these findings in humans, we
    could speculate that growth factors may help future
    patients…. BUT…
   What could be the problem with giving growth factors?
                                       *Joshi et al, Neuroscience, 2010
“Seed”



                       “Soil”




         “Pesticide”
Cancer and Chemotherapy…
   Leads to increased production of inflammatory chemicals called
    cytokines

   e.g. TNF (tumor necrosis factor)

   Higher levels may predict worse cognitive function after
    chemotherapy for breast cancer*

   Some women had genetic differences in the TNF gene that
    made them less likely to develop problems

   What are these differences?

                                            *Ganz, et al, abstract at ASCO, 2011
Single Nucleotide Polymorphisms (SNPs)
   Variations in sequences of DNA
   A single allele is different
   Make us differentially susceptible
    to (or protected from!) all kinds of
    diseases
   Examples:
        TNF
        BDNF (brain-derived neurotropic
         factor)
        Apolipoprotein (ApoE4=more
         prone to Alzheimer’s disease)
   These SNPs may make some
    people unable to repair the DNA
    damage that causes cognitive
    problems
Hormonal therapy for breast cancer may
           also have a negative effect on cognition
   High levels of estrogen increase verbal memory, verbal fluency
    and fine motor skills
   Surgically induced or abrupt menopause
       Acute decline in verbal memory
   It’s unclear that hormone replacement therapy truly protects
    against dementia

   Tamoxifen and aromatase inhibitors (eg Aromasin, Arimidex,
    Femara) may have an anti-estrogen role in some brain areas
    related to cognitive function
       Effects are not widespread or severe
       Primarily seen in verbal memory and processing speed
Chemobrain is associated with several
         common, treatable problems
   Sleep disturbance

   Fatigue

   Depression

   Anxiety
What can be done?
Medications-1
   Stimulants
       methylphenidate (Ritalin, Concerta, Focalin),
        dextroamphetamine (Adderall)
       Despite negative study*, they are sometimes effective in
        clinical practice

   Modafinil (Provigil)*
       Improved attention and memory in a group of breast cancer
        survivors with fatigue


        *Mar Fan et al, Support Care Cancer, 2008
        *Kohli et al, Cancer, 2009
Medications-2
   Antidepressants
        Celexa (citalopram), Zoloft (sertraline), Lexapro (escitalopram), Prozac
         (fluoxetine), Paxil (paroxetine)
        Effexor (venlafaxine), Cymbalta (duloxetine)
        Wellbutrin (bupropion)
        Remeron (mirtazapine)

   Anxiolytics
        lorazepam (Ativan), clonazepam (Klonopin), alprazolam (Xanax), diazepam
         (Valium)
        Use with caution

   Sleep medications
        zolpidem (Ambien), eszopiclone (Lunesta), trazodone (desyrel)
        Use with caution
SSRIs (e.g. citalopram, fluoxetine, sertraline)
increase levels of BDNF, increase neurogenesis,
and increase branching of dendritic connections.
Other Activities
   Regular aerobic exercise

        May improve neural proliferation
         in the dentate gyrus!

        In a review of many studies, this
         was the only factor associated
         with lowering your risk of
         dementia

   Social connections

   Good nutrition
        e.g. fish w/omega 3’s,
         antioxidants, flavanols
First Step: Get Help!
   If you’re more than 6 months out from chemotherapy and you are having difficulty
    functioning in your daily life (with work, school, relationships) due to chemobrain…

   Ask your oncologist for a referral to a neuropsychologist.

   A neurologist can be helpful if you have a family history of dementia, or if you have
    other neurological symptoms such as persistent neuropathy, headaches,
    weakness/numbness in a body part, etc.

   If you have any sleep problems, fatigue, depression, or anxiety:

        Consider seeing a psychiatrist
        Also consider seeing a sleep medicine physician (who can decide if a sleep study is needed).

   Finally, make sure your PCP is in the loop.
Sleep Apnea…
   Weight gain after breast
    cancer treatment puts
    people at higher risk
   Masks are more
    comfortable than they
    used to be
   Don’t give up!!
   Start with a few hours a
    night and work up
    gradually
Cognitive Behavioral Therapy
   Usually delivered by a psychologist, psychiatrist, or
    social worker

   Research shows it’s very effective for depression and
    anxiety

   Doesn’t necessarily change your chemobrain, but
    changes your relationship with your chemobrain

   Corrects negative “automatic thoughts” and distortions
Cognitive Behavioral Therapy
       Triad/Quartet
Filtering: We take the negative details and magnify them while filtering out all positive
       aspects of a situation. For instance, a person may pick out a single, unpleasant detail
       and dwell on it exclusively so that their vision of reality becomes darkened or
       distorted.

“Black and White” Thinking: In polarized thinking, things are either “black-or-white.”
      We have to be perfect or we’re a failure — there is no middle ground. You place
      people or situations in “either/or” categories, with no shades of gray or allowing
      for the complexity of most people and situations. If your performance falls short of
      perfect, you see yourself as a total failure.

Overgeneralization: In this cognitive distortion, we come to a general conclusion based
     on a single incident or a single piece of evidence. If something bad happens only
     once, we expect it to happen over and over again. A person may see a single,
     unpleasant event as part of a never-ending pattern of defeat.

Jumping to Conclusions: Without individuals saying so, we know what they are feeling
     and why they act the way they do. In particular, we are able to determine how
     people are feeling toward us.
     For example, a person may conclude that someone is reacting negatively toward
     them but doesn’t actually bother to find out if they are correct. Another example is
     a person may anticipate that things will turn out badly, and will feel convinced that
     their prediction is already an established fact.

                                             http://psychcentral.com/lib/2009/15-common-cognitive-distortions/
Catastrophizing: We expect disaster to strike, no matter what. This is also referred to as
   “magnifying or minimizing.” We hear about a problem and use what if questions (e.g.,
   “What if tragedy strikes?” “What if it happens to me?”).
  For example, a person might exaggerate the importance of insignificant events (such as
   their mistake, or someone else’s achievement). Or they may inappropriately shrink the
   magnitude of significant events until they appear tiny (for example, a person’s own
   desirable qualities or someone else’s imperfections)
Personalization: Personalization is a distortion where a person believes that everything
   others do or say is some kind of direct, personal reaction to the person. We also compare
   ourselves to others trying to determine who is smarter, better looking, etc.
  A person engaging in personalization may also see themselves as the cause of some
   unhealthy external event that they were not responsible for. For example, “We were late
   to the dinner party and caused the hostess to overcook the meal. If I had only pushed my
   husband to leave on time, this wouldn’t have happened.”
Control Fallacies: If we feel externally controlled, we see ourselves as helpless a victim of fate.
   For example, “I can’t help it if the quality of the work is poor, my boss demanded I work
   overtime on it.” The fallacy of internal control has us assuming responsibility for the pain
   and happiness of everyone around us. For example, “Why aren’t you happy? Is it because
   of something I did?”
Fallacy of Fairness: We feel resentful because we think we know what is fair, but other
    people won’t agree with us. As our parents tell us, “Life is always fair,” and people who go
    through life applying a measuring ruler against every situation judging its “fairness” will
    often feel badly and negative because of it.
Shoulds: We have a list of ironclad rules about how others and we
  should behave. People who break the rules make us angry, and
  we feel guilty when we violate these rules. A person may often
  believe they are trying to motivate themselves with shoulds and
  shouldn’ts, as if they have to be punished before they can do
  anything.
  For example, “I really should exercise. I shouldn’t be so lazy.”
  Musts and oughts are also offenders. The emotional consequence
  is guilt. When a person directs should statements toward others,
  they often feel anger, frustration and resentment.

Emotional Reasoning: We believe that what we feel must be true
 automatically. If we feel stupid and boring, then we must be
 stupid and boring. You assume that your unhealthy emotions
 reflect he way things really are — “I feel it, therefore it must be
 true.”
Naming Emotions
   Anxiety= signal of an emotion that lies underneath
   Primary emotions (like primary colors!)
       Sadness
       Fear
       Anger
       Guilt
       Shame
       Envy
       Jealousy
   Naming the emotion can reduce the anxiety
Behavioral Approaches

   Behavioral activation

   Systematic desensitization
       Gradually exposing yourself to feared situations over
        time
Cognitive rehabilitation helps many patients
   It’s done by a speech-language pathologist
        This is often covered by insurance – specifically, your physical/occupational
         therapy benefit

   Exercises to retrain your brain

   Tracking and understanding what causes cognitive worsening
        e.g. fatigue

   Coping strategies
        PDAs; 1 notebook w/3 sections; Note taking

   Stress relief strategies
        Diaphragmatic breathing; muscle relaxation; guided imagery
The idea behind cognitive rehabilitation is to
 compensate for the deficits by learning to
            work around them




                       “But… I want my backhand to
                       come back!!”
Newest developments are trying
     to take advantage of brain plasticity
              to restore function
   POSIT brain science program
    (http://www.positscience.com)
     40-hour training program
     Effective for age-related cognitive decline and mild
      cognitive impairment
     It’s being studied in chemobrain by Janelle Vardy at
      the University of Sydney
           Study results not yet available
EEG Biofeedback
Preliminary Study of EEG
                Biofeedback
   Preliminary data from Alvarez et al (we are submitting
    to journals presently): 23 breast cancer survivors
    showed marked improvements in self-reported
    cognitive function, sleep, and fatigue after 20 sessions
    of neurofeedback over 10 weeks

   More study with neuropsychological tests is needed.
In order to have chemobrain, you have to be alive

Mais conteúdo relacionado

Mais procurados

Targeted Therapies In Cancer
Targeted Therapies In CancerTargeted Therapies In Cancer
Targeted Therapies In Cancerfondas vakalis
 
Breast Cancer Treatment: Where we are, Where we're going - April 24th, 2018
Breast Cancer Treatment: Where we are, Where we're going - April 24th, 2018Breast Cancer Treatment: Where we are, Where we're going - April 24th, 2018
Breast Cancer Treatment: Where we are, Where we're going - April 24th, 2018Summit Health
 
Chemotherapy Induced Peripheral Neuropathy
Chemotherapy Induced Peripheral NeuropathyChemotherapy Induced Peripheral Neuropathy
Chemotherapy Induced Peripheral NeuropathyEmad Shash
 
Adjuvant chemotherapy of breast cancer
Adjuvant chemotherapy of breast cancerAdjuvant chemotherapy of breast cancer
Adjuvant chemotherapy of breast cancerGita Bhat
 
CINV (chemotherapy induced nausea & vomiting)
CINV (chemotherapy induced nausea & vomiting)CINV (chemotherapy induced nausea & vomiting)
CINV (chemotherapy induced nausea & vomiting)Mohamed Abdulla
 
Personalised medicine in rt dr. ashutosh
Personalised medicine in rt   dr. ashutoshPersonalised medicine in rt   dr. ashutosh
Personalised medicine in rt dr. ashutoshAshutosh Mukherji
 
Satyajeet rath chemotherapy and hormone therapy in breast cancer
Satyajeet rath chemotherapy and hormone therapy in breast cancerSatyajeet rath chemotherapy and hormone therapy in breast cancer
Satyajeet rath chemotherapy and hormone therapy in breast cancerSatyajeet Rath
 
Hormone therapy in carcinoma breast
Hormone therapy in carcinoma breastHormone therapy in carcinoma breast
Hormone therapy in carcinoma breastSailendra Parida
 
Palbociclib in Metastatic Breast Cancer
Palbociclib in Metastatic Breast CancerPalbociclib in Metastatic Breast Cancer
Palbociclib in Metastatic Breast CancerVibhay Pareek
 
Advances in management of castration resistant prostate cancer
Advances in management of castration resistant prostate cancerAdvances in management of castration resistant prostate cancer
Advances in management of castration resistant prostate cancerAlok Gupta
 

Mais procurados (20)

Immunotherapy for Breast Cancer
Immunotherapy for Breast CancerImmunotherapy for Breast Cancer
Immunotherapy for Breast Cancer
 
Targeted Therapies In Cancer
Targeted Therapies In CancerTargeted Therapies In Cancer
Targeted Therapies In Cancer
 
Breast Cancer Treatment: Where we are, Where we're going - April 24th, 2018
Breast Cancer Treatment: Where we are, Where we're going - April 24th, 2018Breast Cancer Treatment: Where we are, Where we're going - April 24th, 2018
Breast Cancer Treatment: Where we are, Where we're going - April 24th, 2018
 
How to Manage Cancer Fatigue
How to Manage Cancer FatigueHow to Manage Cancer Fatigue
How to Manage Cancer Fatigue
 
Impact of sexuality on cancer
Impact of sexuality on cancerImpact of sexuality on cancer
Impact of sexuality on cancer
 
Chemotherapy Induced Peripheral Neuropathy
Chemotherapy Induced Peripheral NeuropathyChemotherapy Induced Peripheral Neuropathy
Chemotherapy Induced Peripheral Neuropathy
 
Adjuvant chemotherapy of breast cancer
Adjuvant chemotherapy of breast cancerAdjuvant chemotherapy of breast cancer
Adjuvant chemotherapy of breast cancer
 
CINV (chemotherapy induced nausea & vomiting)
CINV (chemotherapy induced nausea & vomiting)CINV (chemotherapy induced nausea & vomiting)
CINV (chemotherapy induced nausea & vomiting)
 
Cancer-Related Fatigue Webinar
Cancer-Related Fatigue Webinar Cancer-Related Fatigue Webinar
Cancer-Related Fatigue Webinar
 
Personalised medicine in rt dr. ashutosh
Personalised medicine in rt   dr. ashutoshPersonalised medicine in rt   dr. ashutosh
Personalised medicine in rt dr. ashutosh
 
Satyajeet rath chemotherapy and hormone therapy in breast cancer
Satyajeet rath chemotherapy and hormone therapy in breast cancerSatyajeet rath chemotherapy and hormone therapy in breast cancer
Satyajeet rath chemotherapy and hormone therapy in breast cancer
 
Update in tnbc
Update in tnbcUpdate in tnbc
Update in tnbc
 
ABC1 - R.E. Coleman - Bone metastases
ABC1 - R.E. Coleman - Bone metastases ABC1 - R.E. Coleman - Bone metastases
ABC1 - R.E. Coleman - Bone metastases
 
Hormone therapy in carcinoma breast
Hormone therapy in carcinoma breastHormone therapy in carcinoma breast
Hormone therapy in carcinoma breast
 
Palbociclib in Metastatic Breast Cancer
Palbociclib in Metastatic Breast CancerPalbociclib in Metastatic Breast Cancer
Palbociclib in Metastatic Breast Cancer
 
Cancer screening for seniors
Cancer screening for seniorsCancer screening for seniors
Cancer screening for seniors
 
Oncotype dx
Oncotype dxOncotype dx
Oncotype dx
 
Landmark trials in carcinoma breast
Landmark trials in carcinoma breastLandmark trials in carcinoma breast
Landmark trials in carcinoma breast
 
Advances in management of castration resistant prostate cancer
Advances in management of castration resistant prostate cancerAdvances in management of castration resistant prostate cancer
Advances in management of castration resistant prostate cancer
 
Oer , rbe & let
Oer , rbe & letOer , rbe & let
Oer , rbe & let
 

Semelhante a How to Manage Chemobrain

addiction science.ppt
addiction science.pptaddiction science.ppt
addiction science.pptLeonilEstao
 
Neurobiology of drug abuse and addiction_NIDA
Neurobiology of drug abuse and addiction_NIDANeurobiology of drug abuse and addiction_NIDA
Neurobiology of drug abuse and addiction_NIDAGeorgePanagis3
 
Hani hamed dessoki biological addiction
Hani hamed dessoki biological addictionHani hamed dessoki biological addiction
Hani hamed dessoki biological addictionHani Hamed
 
Biomarkers in psychiatry
Biomarkers in psychiatryBiomarkers in psychiatry
Biomarkers in psychiatryHani Hamed
 
Hanipsych, biomarkers in psychiatry
Hanipsych, biomarkers in psychiatryHanipsych, biomarkers in psychiatry
Hanipsych, biomarkers in psychiatryHani Hamed
 
MedicalResearch.com: Medical Research Exclusive Interviews February 17 2015
MedicalResearch.com:  Medical Research Exclusive Interviews February 17  2015MedicalResearch.com:  Medical Research Exclusive Interviews February 17  2015
MedicalResearch.com: Medical Research Exclusive Interviews February 17 2015Marie Benz MD FAAD
 
Fibromyalgia Fitting the Pieces Together
Fibromyalgia Fitting the Pieces TogetherFibromyalgia Fitting the Pieces Together
Fibromyalgia Fitting the Pieces Togethersmo23915
 
Fibromyalgia: Putting the Pieces Together
Fibromyalgia: Putting the Pieces TogetherFibromyalgia: Putting the Pieces Together
Fibromyalgia: Putting the Pieces Togethersmo23915
 
Addiction In Pregnancy Ver.2
Addiction In Pregnancy Ver.2Addiction In Pregnancy Ver.2
Addiction In Pregnancy Ver.2James Nocon
 
Focussing on cytotoxic treatment alone is not enough
Focussing on cytotoxic treatment alone is not enoughFocussing on cytotoxic treatment alone is not enough
Focussing on cytotoxic treatment alone is not enoughinemet
 
Antidepressants use during Pregnancy/이재라 전임의
Antidepressants  use during Pregnancy/이재라 전임의Antidepressants  use during Pregnancy/이재라 전임의
Antidepressants use during Pregnancy/이재라 전임의mothersafe
 
A guideline for discontinuing antiepileptic drugs in seizure-free patients – ...
A guideline for discontinuing antiepileptic drugs in seizure-free patients – ...A guideline for discontinuing antiepileptic drugs in seizure-free patients – ...
A guideline for discontinuing antiepileptic drugs in seizure-free patients – ...Dr. Rafael Higashi
 
Hanipsych, stress
Hanipsych, stressHanipsych, stress
Hanipsych, stressHani Hamed
 
Difficulties in Treating Patients with Traumatic Brain injury
Difficulties in Treating Patients with Traumatic Brain injuryDifficulties in Treating Patients with Traumatic Brain injury
Difficulties in Treating Patients with Traumatic Brain injuryjamesyoungmd
 
Medulloblastoma - A Closer Look
Medulloblastoma - A Closer LookMedulloblastoma - A Closer Look
Medulloblastoma - A Closer LookHerbert Engelhard
 
Xyzmusts to know about internet addiction (1)
Xyzmusts to know about internet addiction (1)Xyzmusts to know about internet addiction (1)
Xyzmusts to know about internet addiction (1)Milen Ramos
 

Semelhante a How to Manage Chemobrain (20)

Brain Science
Brain ScienceBrain Science
Brain Science
 
addiction science.ppt
addiction science.pptaddiction science.ppt
addiction science.ppt
 
Neurobiology of drug abuse and addiction_NIDA
Neurobiology of drug abuse and addiction_NIDANeurobiology of drug abuse and addiction_NIDA
Neurobiology of drug abuse and addiction_NIDA
 
Hani hamed dessoki biological addiction
Hani hamed dessoki biological addictionHani hamed dessoki biological addiction
Hani hamed dessoki biological addiction
 
Brain tumor.pptx
Brain tumor.pptxBrain tumor.pptx
Brain tumor.pptx
 
Brain Tumor
Brain TumorBrain Tumor
Brain Tumor
 
Biomarkers in psychiatry
Biomarkers in psychiatryBiomarkers in psychiatry
Biomarkers in psychiatry
 
Hanipsych, biomarkers in psychiatry
Hanipsych, biomarkers in psychiatryHanipsych, biomarkers in psychiatry
Hanipsych, biomarkers in psychiatry
 
MedicalResearch.com: Medical Research Exclusive Interviews February 17 2015
MedicalResearch.com:  Medical Research Exclusive Interviews February 17  2015MedicalResearch.com:  Medical Research Exclusive Interviews February 17  2015
MedicalResearch.com: Medical Research Exclusive Interviews February 17 2015
 
Fibromyalgia Fitting the Pieces Together
Fibromyalgia Fitting the Pieces TogetherFibromyalgia Fitting the Pieces Together
Fibromyalgia Fitting the Pieces Together
 
Fibromyalgia: Putting the Pieces Together
Fibromyalgia: Putting the Pieces TogetherFibromyalgia: Putting the Pieces Together
Fibromyalgia: Putting the Pieces Together
 
Addiction In Pregnancy Ver.2
Addiction In Pregnancy Ver.2Addiction In Pregnancy Ver.2
Addiction In Pregnancy Ver.2
 
Focussing on cytotoxic treatment alone is not enough
Focussing on cytotoxic treatment alone is not enoughFocussing on cytotoxic treatment alone is not enough
Focussing on cytotoxic treatment alone is not enough
 
Antidepressants use during Pregnancy/이재라 전임의
Antidepressants  use during Pregnancy/이재라 전임의Antidepressants  use during Pregnancy/이재라 전임의
Antidepressants use during Pregnancy/이재라 전임의
 
A guideline for discontinuing antiepileptic drugs in seizure-free patients – ...
A guideline for discontinuing antiepileptic drugs in seizure-free patients – ...A guideline for discontinuing antiepileptic drugs in seizure-free patients – ...
A guideline for discontinuing antiepileptic drugs in seizure-free patients – ...
 
Hanipsych, stress
Hanipsych, stressHanipsych, stress
Hanipsych, stress
 
Difficulties in Treating Patients with Traumatic Brain injury
Difficulties in Treating Patients with Traumatic Brain injuryDifficulties in Treating Patients with Traumatic Brain injury
Difficulties in Treating Patients with Traumatic Brain injury
 
Medulloblastoma - A Closer Look
Medulloblastoma - A Closer LookMedulloblastoma - A Closer Look
Medulloblastoma - A Closer Look
 
Xyzmusts to know about internet addiction (1)
Xyzmusts to know about internet addiction (1)Xyzmusts to know about internet addiction (1)
Xyzmusts to know about internet addiction (1)
 
Chemotherapeutic agents
Chemotherapeutic agentsChemotherapeutic agents
Chemotherapeutic agents
 

Mais de Dana-Farber Cancer Institute

Personal Finance Tips for Young Adults with Cancer
Personal Finance Tips for Young Adults with Cancer Personal Finance Tips for Young Adults with Cancer
Personal Finance Tips for Young Adults with Cancer Dana-Farber Cancer Institute
 
How are Adult and Childhood Leukemia Alike and Different?
How are Adult and Childhood Leukemia Alike and Different?How are Adult and Childhood Leukemia Alike and Different?
How are Adult and Childhood Leukemia Alike and Different?Dana-Farber Cancer Institute
 
Research in the Program for Young Women with Breast Cancer: Past, Present and...
Research in the Program for Young Women with Breast Cancer: Past, Present and...Research in the Program for Young Women with Breast Cancer: Past, Present and...
Research in the Program for Young Women with Breast Cancer: Past, Present and...Dana-Farber Cancer Institute
 
Clinical Trials for Metastatic HER2-positive Breast Cancer
Clinical Trials for Metastatic HER2-positive Breast CancerClinical Trials for Metastatic HER2-positive Breast Cancer
Clinical Trials for Metastatic HER2-positive Breast CancerDana-Farber Cancer Institute
 
Clinical Trials for Metastatic Triple-Negative Breast Cancer
Clinical Trials for Metastatic Triple-Negative Breast CancerClinical Trials for Metastatic Triple-Negative Breast Cancer
Clinical Trials for Metastatic Triple-Negative Breast CancerDana-Farber Cancer Institute
 
Surgery for Inflammatory Breast Cancer: How and Why
Surgery for Inflammatory Breast Cancer: How and WhySurgery for Inflammatory Breast Cancer: How and Why
Surgery for Inflammatory Breast Cancer: How and WhyDana-Farber Cancer Institute
 
Primary Systemic Therapy for Inflammatory Breast Cancer
Primary Systemic Therapy for Inflammatory Breast CancerPrimary Systemic Therapy for Inflammatory Breast Cancer
Primary Systemic Therapy for Inflammatory Breast CancerDana-Farber Cancer Institute
 
7 Ways Integrative Therapies Can Help Cancer Patients
7 Ways Integrative Therapies Can Help Cancer Patients7 Ways Integrative Therapies Can Help Cancer Patients
7 Ways Integrative Therapies Can Help Cancer PatientsDana-Farber Cancer Institute
 

Mais de Dana-Farber Cancer Institute (20)

Exercise Tips for Cancer Patients
Exercise Tips for Cancer Patients Exercise Tips for Cancer Patients
Exercise Tips for Cancer Patients
 
Personal Finance Tips for Young Adults with Cancer
Personal Finance Tips for Young Adults with Cancer Personal Finance Tips for Young Adults with Cancer
Personal Finance Tips for Young Adults with Cancer
 
5 Things to Know About Glioblastomas
5 Things to Know About Glioblastomas5 Things to Know About Glioblastomas
5 Things to Know About Glioblastomas
 
How are Adult and Childhood Leukemia Alike and Different?
How are Adult and Childhood Leukemia Alike and Different?How are Adult and Childhood Leukemia Alike and Different?
How are Adult and Childhood Leukemia Alike and Different?
 
Research in the Program for Young Women with Breast Cancer: Past, Present and...
Research in the Program for Young Women with Breast Cancer: Past, Present and...Research in the Program for Young Women with Breast Cancer: Past, Present and...
Research in the Program for Young Women with Breast Cancer: Past, Present and...
 
Clinical Trials for Metastatic HER2-positive Breast Cancer
Clinical Trials for Metastatic HER2-positive Breast CancerClinical Trials for Metastatic HER2-positive Breast Cancer
Clinical Trials for Metastatic HER2-positive Breast Cancer
 
Clinical Trials for Metastatic Triple-Negative Breast Cancer
Clinical Trials for Metastatic Triple-Negative Breast CancerClinical Trials for Metastatic Triple-Negative Breast Cancer
Clinical Trials for Metastatic Triple-Negative Breast Cancer
 
Healthy Living After A Breast Cancer Diagnosis
Healthy Living After A Breast Cancer DiagnosisHealthy Living After A Breast Cancer Diagnosis
Healthy Living After A Breast Cancer Diagnosis
 
Signs and Symptoms of Prostate Cancer
Signs and Symptoms of Prostate CancerSigns and Symptoms of Prostate Cancer
Signs and Symptoms of Prostate Cancer
 
6 Common Types of Pediatric Brain Tumors
6 Common Types of Pediatric Brain Tumors6 Common Types of Pediatric Brain Tumors
6 Common Types of Pediatric Brain Tumors
 
Soft Tissue Sarcomas: Symptoms and Risk Factors
Soft Tissue Sarcomas: Symptoms and Risk FactorsSoft Tissue Sarcomas: Symptoms and Risk Factors
Soft Tissue Sarcomas: Symptoms and Risk Factors
 
10 Tips for Easing Chemo-Related Fatigue
10 Tips for Easing Chemo-Related Fatigue10 Tips for Easing Chemo-Related Fatigue
10 Tips for Easing Chemo-Related Fatigue
 
Surgery for Inflammatory Breast Cancer: How and Why
Surgery for Inflammatory Breast Cancer: How and WhySurgery for Inflammatory Breast Cancer: How and Why
Surgery for Inflammatory Breast Cancer: How and Why
 
Radiation Therapy for Inflammatory Breast Cancer
Radiation Therapy for Inflammatory Breast CancerRadiation Therapy for Inflammatory Breast Cancer
Radiation Therapy for Inflammatory Breast Cancer
 
Primary Systemic Therapy for Inflammatory Breast Cancer
Primary Systemic Therapy for Inflammatory Breast CancerPrimary Systemic Therapy for Inflammatory Breast Cancer
Primary Systemic Therapy for Inflammatory Breast Cancer
 
What Cancers Should Men Be Screened For?
What Cancers Should Men Be Screened For?What Cancers Should Men Be Screened For?
What Cancers Should Men Be Screened For?
 
Five Common Types of Brain Tumors
Five Common Types of Brain TumorsFive Common Types of Brain Tumors
Five Common Types of Brain Tumors
 
Signs and Symptoms of Multiple Myeloma
Signs and Symptoms of Multiple MyelomaSigns and Symptoms of Multiple Myeloma
Signs and Symptoms of Multiple Myeloma
 
7 Ways Integrative Therapies Can Help Cancer Patients
7 Ways Integrative Therapies Can Help Cancer Patients7 Ways Integrative Therapies Can Help Cancer Patients
7 Ways Integrative Therapies Can Help Cancer Patients
 
Five Things You Need to Know About Colon Cancer
Five Things You Need to Know About Colon CancerFive Things You Need to Know About Colon Cancer
Five Things You Need to Know About Colon Cancer
 

Último

PHYSIOTHERAPY IN HEART TRANSPLANTATION..
PHYSIOTHERAPY IN HEART TRANSPLANTATION..PHYSIOTHERAPY IN HEART TRANSPLANTATION..
PHYSIOTHERAPY IN HEART TRANSPLANTATION..AneriPatwari
 
HERBS AS HEALTH FOOD - Brief introduction and therapeutic applications of: N...
HERBS AS HEALTH FOOD - Brief introduction and therapeutic applications of:  N...HERBS AS HEALTH FOOD - Brief introduction and therapeutic applications of:  N...
HERBS AS HEALTH FOOD - Brief introduction and therapeutic applications of: N...Divya Kanojiya
 
Presentation on Parasympathetic Nervous System
Presentation on Parasympathetic Nervous SystemPresentation on Parasympathetic Nervous System
Presentation on Parasympathetic Nervous SystemPrerana Jadhav
 
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...Badalona Serveis Assistencials
 
Giftedness: Understanding Everyday Neurobiology for Self-Knowledge
Giftedness: Understanding Everyday Neurobiology for Self-KnowledgeGiftedness: Understanding Everyday Neurobiology for Self-Knowledge
Giftedness: Understanding Everyday Neurobiology for Self-Knowledgeassessoriafabianodea
 
Primary headache and facial pain. (2024)
Primary headache and facial pain. (2024)Primary headache and facial pain. (2024)
Primary headache and facial pain. (2024)Mohamed Rizk Khodair
 
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara Rajendran
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara RajendranMusic Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara Rajendran
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara RajendranTara Rajendran
 
Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...
Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...
Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...MehranMouzam
 
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaurMETHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaurNavdeep Kaur
 
PULMONARY EDEMA AND ITS MANAGEMENT.pdf
PULMONARY EDEMA AND  ITS  MANAGEMENT.pdfPULMONARY EDEMA AND  ITS  MANAGEMENT.pdf
PULMONARY EDEMA AND ITS MANAGEMENT.pdfDolisha Warbi
 
Culture and Health Disorders Social change.pptx
Culture and Health Disorders Social change.pptxCulture and Health Disorders Social change.pptx
Culture and Health Disorders Social change.pptxDr. Dheeraj Kumar
 
Nutrition of OCD for my Nutritional Neuroscience Class
Nutrition of OCD for my Nutritional Neuroscience ClassNutrition of OCD for my Nutritional Neuroscience Class
Nutrition of OCD for my Nutritional Neuroscience Classmanuelazg2001
 
Big Data Analysis Suggests COVID Vaccination Increases Excess Mortality Of ...
Big Data Analysis Suggests COVID  Vaccination Increases Excess Mortality Of  ...Big Data Analysis Suggests COVID  Vaccination Increases Excess Mortality Of  ...
Big Data Analysis Suggests COVID Vaccination Increases Excess Mortality Of ...sdateam0
 
epilepsy and status epilepticus for undergraduate.pptx
epilepsy and status epilepticus  for undergraduate.pptxepilepsy and status epilepticus  for undergraduate.pptx
epilepsy and status epilepticus for undergraduate.pptxMohamed Rizk Khodair
 
Role of medicinal and aromatic plants in national economy PDF.pdf
Role of medicinal and aromatic plants in national economy PDF.pdfRole of medicinal and aromatic plants in national economy PDF.pdf
Role of medicinal and aromatic plants in national economy PDF.pdfDivya Kanojiya
 
Basic principles involved in the traditional systems of medicine PDF.pdf
Basic principles involved in the traditional systems of medicine PDF.pdfBasic principles involved in the traditional systems of medicine PDF.pdf
Basic principles involved in the traditional systems of medicine PDF.pdfDivya Kanojiya
 
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptx
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptxSYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptx
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptxdrashraf369
 
Valproic Acid. (VPA). Antiseizure medication
Valproic Acid.  (VPA). Antiseizure medicationValproic Acid.  (VPA). Antiseizure medication
Valproic Acid. (VPA). Antiseizure medicationMohamadAlhes
 
Apiculture Chapter 1. Introduction 2.ppt
Apiculture Chapter 1. Introduction 2.pptApiculture Chapter 1. Introduction 2.ppt
Apiculture Chapter 1. Introduction 2.pptkedirjemalharun
 

Último (20)

PHYSIOTHERAPY IN HEART TRANSPLANTATION..
PHYSIOTHERAPY IN HEART TRANSPLANTATION..PHYSIOTHERAPY IN HEART TRANSPLANTATION..
PHYSIOTHERAPY IN HEART TRANSPLANTATION..
 
HERBS AS HEALTH FOOD - Brief introduction and therapeutic applications of: N...
HERBS AS HEALTH FOOD - Brief introduction and therapeutic applications of:  N...HERBS AS HEALTH FOOD - Brief introduction and therapeutic applications of:  N...
HERBS AS HEALTH FOOD - Brief introduction and therapeutic applications of: N...
 
Presentation on Parasympathetic Nervous System
Presentation on Parasympathetic Nervous SystemPresentation on Parasympathetic Nervous System
Presentation on Parasympathetic Nervous System
 
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
 
Giftedness: Understanding Everyday Neurobiology for Self-Knowledge
Giftedness: Understanding Everyday Neurobiology for Self-KnowledgeGiftedness: Understanding Everyday Neurobiology for Self-Knowledge
Giftedness: Understanding Everyday Neurobiology for Self-Knowledge
 
Primary headache and facial pain. (2024)
Primary headache and facial pain. (2024)Primary headache and facial pain. (2024)
Primary headache and facial pain. (2024)
 
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara Rajendran
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara RajendranMusic Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara Rajendran
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara Rajendran
 
Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...
Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...
Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...
 
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaurMETHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
 
PULMONARY EDEMA AND ITS MANAGEMENT.pdf
PULMONARY EDEMA AND  ITS  MANAGEMENT.pdfPULMONARY EDEMA AND  ITS  MANAGEMENT.pdf
PULMONARY EDEMA AND ITS MANAGEMENT.pdf
 
Culture and Health Disorders Social change.pptx
Culture and Health Disorders Social change.pptxCulture and Health Disorders Social change.pptx
Culture and Health Disorders Social change.pptx
 
Nutrition of OCD for my Nutritional Neuroscience Class
Nutrition of OCD for my Nutritional Neuroscience ClassNutrition of OCD for my Nutritional Neuroscience Class
Nutrition of OCD for my Nutritional Neuroscience Class
 
Big Data Analysis Suggests COVID Vaccination Increases Excess Mortality Of ...
Big Data Analysis Suggests COVID  Vaccination Increases Excess Mortality Of  ...Big Data Analysis Suggests COVID  Vaccination Increases Excess Mortality Of  ...
Big Data Analysis Suggests COVID Vaccination Increases Excess Mortality Of ...
 
JANGAMA VISHA .pptx-
JANGAMA VISHA .pptx-JANGAMA VISHA .pptx-
JANGAMA VISHA .pptx-
 
epilepsy and status epilepticus for undergraduate.pptx
epilepsy and status epilepticus  for undergraduate.pptxepilepsy and status epilepticus  for undergraduate.pptx
epilepsy and status epilepticus for undergraduate.pptx
 
Role of medicinal and aromatic plants in national economy PDF.pdf
Role of medicinal and aromatic plants in national economy PDF.pdfRole of medicinal and aromatic plants in national economy PDF.pdf
Role of medicinal and aromatic plants in national economy PDF.pdf
 
Basic principles involved in the traditional systems of medicine PDF.pdf
Basic principles involved in the traditional systems of medicine PDF.pdfBasic principles involved in the traditional systems of medicine PDF.pdf
Basic principles involved in the traditional systems of medicine PDF.pdf
 
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptx
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptxSYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptx
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptx
 
Valproic Acid. (VPA). Antiseizure medication
Valproic Acid.  (VPA). Antiseizure medicationValproic Acid.  (VPA). Antiseizure medication
Valproic Acid. (VPA). Antiseizure medication
 
Apiculture Chapter 1. Introduction 2.ppt
Apiculture Chapter 1. Introduction 2.pptApiculture Chapter 1. Introduction 2.ppt
Apiculture Chapter 1. Introduction 2.ppt
 

How to Manage Chemobrain

  • 1. Cognitive Changes after Breast Cancer and its Treatment Fremonta Meyer, MD Department of Psychosocial Oncology and Palliative Care Dana-Farber Cancer Institute June 6, 2012
  • 2. Outline  Impact  Why focus on breast cancer?  Research findings  Interventions
  • 3. What symptoms are you experiencing?
  • 4. So…  Is it real?  What causes it?  What can be done about it?
  • 5. Patient Experiences  “I have been so lost [while driving], I just pull over, and break down and start crying. Because it’s places I’ve been before and I know where I am going…”  “I couldn’t remember if I looked at a stoplight. I felt like it was putting myself at risk.”  “What I have to do sometimes is have my son come over and pay my bills.”* * Boykoff et al, J Cancer Surviv, 2009
  • 6. Impact on Quality of Life  Distress due to lack of acknowledgment by medical community  Mixed reactions from family and friends  Decline in job performance  Avoidance of social occasions  Depression and anxiety * Boykoff et al, J Cancer Surviv, 2009
  • 7. Chemobrain can affect many areas of cognitive function  Memory  Attention/concentration  Information processing speed  Executive function  Initiation  Planning  Organization  Multi-tasking  Response inhibition
  • 8. Research shows that the majority of patients on chemotherapy experience cognitive side effects  67% of patients reported experiencing memory and concentration problems during chemotherapy  These problems were still present 6 months after completing chemotherapy Memory Concentration *Kohli et al, J Oncol Practice, 2007
  • 9. For most people, chemobrain gradually disappears over time  17-34% of people continue to have problems after the end of chemotherapy  Some neuroimaging studies show improvement/resolution of regional brain volume differences as of 3 years post- chemotherapy *Inagaki et al, Cancer, 2007
  • 10. Chemobrain leads to dysfunction of frontal-subcortical brain networks
  • 11. Chemobrain is not the same as dementia  Chemobrain is not a progressive condition  Chemobrain does not increase risk for Alzheimer’s disease  The cognitive findings in Alzheimer’s disease are different  In Alzheimer’s, memory cues don’t help  In chemobrain, memory cues help
  • 12. *Ferguson et al, JCO, 2007
  • 13. Why do we study breast cancer?  Common cancer with largest population of survivors (23%; 2.6 million)  Limited direct effects of cancer on brain other than chemotherapy  Population allows chemotherapy vs non- chemotherapy study designs
  • 14. Why don’t more oncologists study this?  Oncology research tends to focus on clearly defined outcomes or “endpoints”  Overall survival (OS)  Progression-free survival (PS)  What’s the “endpoint” for chemobrain?
  • 15. Endpoints for chemobrain are controversial.  Functional neuroimaging findings (fMRI)  Neuropsychological tests  May not reflect “real life”  Self-reported cognitive problems  May have other causes  But, interestingly, seems to be most similar to fMRI results
  • 16. Empathy for your oncologist and other physicians…  It’s important to understand where your oncologist is coming from…  The research on this topic is very confusing  There aren’t yet any FDA approved treatments for chemobrain  This makes it hard for them to know what to recommend!
  • 17. Problems with the Older Research  Cross-sectional studies  Looking only at people who already completed cancer treatment  Prospective studies without matched control groups  Looking only at people who had cancer and received chemotherapy  Not enough patients  Multiple chemotherapy regimens  Not controlling for hormonal therapies  Not controlling for patients getting better at neuropsychological tests because they have practiced them (rather than their chemobrain actually improving)  Excluding people with depression, anxiety, sleep problems
  • 18.
  • 19. Summary of the better-quality research using neuropsychological testing  8 prospective longitudinal studies with matched control +/- healthy control group*  Acute declines in motor skills, processing speed, verbal/visual memory which improved over time  Chemotherapy may have specific negative effect on verbal fluency  Patients exposed to chemotherapy plus tamoxifen did worse at later timepoints than pts exposed to chemotherapy alone  But: 3 studies did not show any cognitive impairment with standard-dose chemotherapy *Quesnel 2009, Schagen 2009, Tager 2010, Bender 2006, Collins 2009, Jenkins 2006, Mehlsen 2009, Ahles 2010
  • 20. How would you design a study, from your perspective as a cancer survivor?
  • 21. Added Observations  Some people with breast cancer (11-33%) have cognitive problems prior to receiving any chemotherapy at all*  Anxiety  Anesthesia from surgeries  Something that the tumor directly causes – “paraneoplastic” *Ahles et al, Breast Cancer Res Treat, 2008
  • 22. The dentate gyrus of the hippocampus is involved in the formation of new memories
  • 23. A Close-Up of the Dentate Gyrus
  • 24. What chemotherapy regimens do most women receive for breast cancer?  “AC” then “T”:  A=adriamycin (doxorubicin)  C=cyclophosphamide (Cytoxan)  T=docetaxel (Taxotere)
  • 25. What is the blood-brain barrier (BBB)?  Microscopic objects (e.g. bacteria) can’t get in. Neither can hydrophilic molecules. But it doesn’t keep everything out…
  • 26. Cyclophosphamide (cytoxan) and 5- fluorouracil (often used in treatment for colon cancer) can cross the BBB.  Doxorubicin and paclitaxel do not directly cross the BBB.
  • 27. In mice, chemotherapy agents appear to result in reduced cell growth in the dentate gyrus of the hippocampus *Janelsins et al, Cancer Investigation, 2010
  • 28. Take-Home Points  Even chemotherapies that do not cross the BBB (such as doxorubicin and doxetaxel/paclitaxel) may result in decreased neurogenesis (growth of neurons)  Growth factors may result in increased survival of neural cells  IGF-1, BDNF, VEGF, FGF  So, if we can confirm these findings in humans, we could speculate that growth factors may help future patients…. BUT…  What could be the problem with giving growth factors? *Joshi et al, Neuroscience, 2010
  • 29. “Seed” “Soil” “Pesticide”
  • 30. Cancer and Chemotherapy…  Leads to increased production of inflammatory chemicals called cytokines  e.g. TNF (tumor necrosis factor)  Higher levels may predict worse cognitive function after chemotherapy for breast cancer*  Some women had genetic differences in the TNF gene that made them less likely to develop problems  What are these differences? *Ganz, et al, abstract at ASCO, 2011
  • 31. Single Nucleotide Polymorphisms (SNPs)  Variations in sequences of DNA  A single allele is different  Make us differentially susceptible to (or protected from!) all kinds of diseases  Examples:  TNF  BDNF (brain-derived neurotropic factor)  Apolipoprotein (ApoE4=more prone to Alzheimer’s disease)  These SNPs may make some people unable to repair the DNA damage that causes cognitive problems
  • 32. Hormonal therapy for breast cancer may also have a negative effect on cognition  High levels of estrogen increase verbal memory, verbal fluency and fine motor skills  Surgically induced or abrupt menopause  Acute decline in verbal memory  It’s unclear that hormone replacement therapy truly protects against dementia  Tamoxifen and aromatase inhibitors (eg Aromasin, Arimidex, Femara) may have an anti-estrogen role in some brain areas related to cognitive function  Effects are not widespread or severe  Primarily seen in verbal memory and processing speed
  • 33. Chemobrain is associated with several common, treatable problems  Sleep disturbance  Fatigue  Depression  Anxiety
  • 34. What can be done?
  • 35. Medications-1  Stimulants  methylphenidate (Ritalin, Concerta, Focalin), dextroamphetamine (Adderall)  Despite negative study*, they are sometimes effective in clinical practice  Modafinil (Provigil)*  Improved attention and memory in a group of breast cancer survivors with fatigue *Mar Fan et al, Support Care Cancer, 2008 *Kohli et al, Cancer, 2009
  • 36. Medications-2  Antidepressants  Celexa (citalopram), Zoloft (sertraline), Lexapro (escitalopram), Prozac (fluoxetine), Paxil (paroxetine)  Effexor (venlafaxine), Cymbalta (duloxetine)  Wellbutrin (bupropion)  Remeron (mirtazapine)  Anxiolytics  lorazepam (Ativan), clonazepam (Klonopin), alprazolam (Xanax), diazepam (Valium)  Use with caution  Sleep medications  zolpidem (Ambien), eszopiclone (Lunesta), trazodone (desyrel)  Use with caution
  • 37. SSRIs (e.g. citalopram, fluoxetine, sertraline) increase levels of BDNF, increase neurogenesis, and increase branching of dendritic connections.
  • 38. Other Activities  Regular aerobic exercise  May improve neural proliferation in the dentate gyrus!  In a review of many studies, this was the only factor associated with lowering your risk of dementia  Social connections  Good nutrition  e.g. fish w/omega 3’s, antioxidants, flavanols
  • 39. First Step: Get Help!  If you’re more than 6 months out from chemotherapy and you are having difficulty functioning in your daily life (with work, school, relationships) due to chemobrain…  Ask your oncologist for a referral to a neuropsychologist.  A neurologist can be helpful if you have a family history of dementia, or if you have other neurological symptoms such as persistent neuropathy, headaches, weakness/numbness in a body part, etc.  If you have any sleep problems, fatigue, depression, or anxiety:  Consider seeing a psychiatrist  Also consider seeing a sleep medicine physician (who can decide if a sleep study is needed).  Finally, make sure your PCP is in the loop.
  • 40. Sleep Apnea…  Weight gain after breast cancer treatment puts people at higher risk  Masks are more comfortable than they used to be  Don’t give up!!  Start with a few hours a night and work up gradually
  • 41. Cognitive Behavioral Therapy  Usually delivered by a psychologist, psychiatrist, or social worker  Research shows it’s very effective for depression and anxiety  Doesn’t necessarily change your chemobrain, but changes your relationship with your chemobrain  Corrects negative “automatic thoughts” and distortions
  • 43. Filtering: We take the negative details and magnify them while filtering out all positive aspects of a situation. For instance, a person may pick out a single, unpleasant detail and dwell on it exclusively so that their vision of reality becomes darkened or distorted. “Black and White” Thinking: In polarized thinking, things are either “black-or-white.” We have to be perfect or we’re a failure — there is no middle ground. You place people or situations in “either/or” categories, with no shades of gray or allowing for the complexity of most people and situations. If your performance falls short of perfect, you see yourself as a total failure. Overgeneralization: In this cognitive distortion, we come to a general conclusion based on a single incident or a single piece of evidence. If something bad happens only once, we expect it to happen over and over again. A person may see a single, unpleasant event as part of a never-ending pattern of defeat. Jumping to Conclusions: Without individuals saying so, we know what they are feeling and why they act the way they do. In particular, we are able to determine how people are feeling toward us. For example, a person may conclude that someone is reacting negatively toward them but doesn’t actually bother to find out if they are correct. Another example is a person may anticipate that things will turn out badly, and will feel convinced that their prediction is already an established fact. http://psychcentral.com/lib/2009/15-common-cognitive-distortions/
  • 44. Catastrophizing: We expect disaster to strike, no matter what. This is also referred to as “magnifying or minimizing.” We hear about a problem and use what if questions (e.g., “What if tragedy strikes?” “What if it happens to me?”). For example, a person might exaggerate the importance of insignificant events (such as their mistake, or someone else’s achievement). Or they may inappropriately shrink the magnitude of significant events until they appear tiny (for example, a person’s own desirable qualities or someone else’s imperfections) Personalization: Personalization is a distortion where a person believes that everything others do or say is some kind of direct, personal reaction to the person. We also compare ourselves to others trying to determine who is smarter, better looking, etc. A person engaging in personalization may also see themselves as the cause of some unhealthy external event that they were not responsible for. For example, “We were late to the dinner party and caused the hostess to overcook the meal. If I had only pushed my husband to leave on time, this wouldn’t have happened.” Control Fallacies: If we feel externally controlled, we see ourselves as helpless a victim of fate. For example, “I can’t help it if the quality of the work is poor, my boss demanded I work overtime on it.” The fallacy of internal control has us assuming responsibility for the pain and happiness of everyone around us. For example, “Why aren’t you happy? Is it because of something I did?” Fallacy of Fairness: We feel resentful because we think we know what is fair, but other people won’t agree with us. As our parents tell us, “Life is always fair,” and people who go through life applying a measuring ruler against every situation judging its “fairness” will often feel badly and negative because of it.
  • 45. Shoulds: We have a list of ironclad rules about how others and we should behave. People who break the rules make us angry, and we feel guilty when we violate these rules. A person may often believe they are trying to motivate themselves with shoulds and shouldn’ts, as if they have to be punished before they can do anything. For example, “I really should exercise. I shouldn’t be so lazy.” Musts and oughts are also offenders. The emotional consequence is guilt. When a person directs should statements toward others, they often feel anger, frustration and resentment. Emotional Reasoning: We believe that what we feel must be true automatically. If we feel stupid and boring, then we must be stupid and boring. You assume that your unhealthy emotions reflect he way things really are — “I feel it, therefore it must be true.”
  • 46. Naming Emotions  Anxiety= signal of an emotion that lies underneath  Primary emotions (like primary colors!)  Sadness  Fear  Anger  Guilt  Shame  Envy  Jealousy  Naming the emotion can reduce the anxiety
  • 47. Behavioral Approaches  Behavioral activation  Systematic desensitization  Gradually exposing yourself to feared situations over time
  • 48. Cognitive rehabilitation helps many patients  It’s done by a speech-language pathologist  This is often covered by insurance – specifically, your physical/occupational therapy benefit  Exercises to retrain your brain  Tracking and understanding what causes cognitive worsening  e.g. fatigue  Coping strategies  PDAs; 1 notebook w/3 sections; Note taking  Stress relief strategies  Diaphragmatic breathing; muscle relaxation; guided imagery
  • 49. The idea behind cognitive rehabilitation is to compensate for the deficits by learning to work around them “But… I want my backhand to come back!!”
  • 50. Newest developments are trying to take advantage of brain plasticity to restore function  POSIT brain science program (http://www.positscience.com)  40-hour training program  Effective for age-related cognitive decline and mild cognitive impairment  It’s being studied in chemobrain by Janelle Vardy at the University of Sydney  Study results not yet available
  • 52. Preliminary Study of EEG Biofeedback  Preliminary data from Alvarez et al (we are submitting to journals presently): 23 breast cancer survivors showed marked improvements in self-reported cognitive function, sleep, and fatigue after 20 sessions of neurofeedback over 10 weeks  More study with neuropsychological tests is needed.
  • 53. In order to have chemobrain, you have to be alive

Notas do Editor

  1. Lost wages, credit card late fees, higher car insurance premiums. “My condition is as real as the cost has been.”
  2. This was a study done in 2007 in about 600 patients who were being treated with chemotherapy and radiation for solid tumors. Patients self-reported any problems with memory and concentration. Women had more symptoms than men during treatment. About ½ of patients had problems at baseline, before any treatment. This went up to 67% during treatment, and remained at 50-60% 6 months after treatment. The graphs show that chemo was significantly more likely to cause problems than radiation. They also show that for most patients, the problems were fairly mild (0=no problem; 10=worst problem you could imagine). But they suggest that people are still having some trouble 6 months after chemotherapy ends.
  3. Basal ganglia- control the decision of which of several possible behaviors to execute at a given time
  4. This was a study of 60 y/o twins who were raised together. Twin A had breast cancer and was 2 years out from chemotherapy; twin B did not have cancer. They put both twins in a functional MRI scanner. They tested working memory by asking the twins to listen to a string of letters presented once every 3 seconds. The twins had to press a button if the letter was a match with a designated target (e.g. “F”) or if it was the same as the letter presented 3 back in the sequence (e.g. “C”). The results were that both twins were equally accurate at the task. But twin A (top) had to activate a much larger area of the brain than twin B did. So, this may translate into twin A experiencing the task as more difficult.
  5. And anecdotally, breast cancer survivors complain about this a lot.
  6. Don ’t have OS or PS like oncologists!!
  7. Most objective to least objective ; most expensive to least expensive
  8. Unlikely to be stress of dx, given findings in stage 0 patients vs stage I-III pts. RF: higher levels of proinflammatory cytokines may be correlated with both cancer and MCI/AlzD, or polymorphisms in DNA repair genes
  9. In this study (published in early 2011) researchers wanted to see if the chemo drugs that cross the BBB were more likely to interfere with growth of neurons than the chemo drugs that don ’t cross the BBB. They took mice and gave 1 group saline and the other group chemotherapy. On the 2 nd day, they injected all the mice with a tracer chemical that binds to neurons. On the 3 rd day, they sacrificed the mice and isolated their brains. Then after 5 days of incubation they examined the dentate gyrus. What they found was that all of the 4 chemotherapy drugs, even the 2 that don’t cross the BBB, caused reduced growth of neurons. The reductions ranged from 15% to 36%. There was no cell death – only a slowing in growth.
  10. Growth factors are proteins that stimulate cells to grow and mature. Some of you probably took Neupogen during chemotherapy (G-CSF). This is a growth factor that stimulates white blood cells to grow. They are many others which make other cells (including neurons) grow.
  11. b/c Self-reported cognitive dysfunction correlates with these sx – NOT objective cognitive findings
  12. In a study published on Jan. 31, 2011, in The Proceedings of the National Academy of Sciences, researchers randomly assigned 120 healthy but sedentary men and women (average age mid-60s) to one of two exercise groups. One group walked around a track three times a week, building up to 40 minutes at a stretch; the other did a variety of less aerobic exercises, including yoga and resistance training with bands. After a year, brain scans showed that among the walkers, the hippocampus had increased in volume by about 2 percent on average; in the others, it had declined by about 1.4 percent. Since such a decline is normal in older adults, “a 2 percent increase is fairly significant,” said the lead author, Kirk Erickson, a psychologist at the University of Pittsburgh. Both groups also improved on a test of spatial memory, but the walkers improved more.
  13. I think it ’s important to mention here that there is a stigma associated with seeking help for emotional problems. Many of you may never have done this before cancer. But I think at the same time when you’re in this situation it’s even more important to challenge yourself on that stigma and take advantage of any resources that may be able to help you.
  14. I ’m a psychiatrist, so I can’t get through a talk without focusing on some of the areas
  15. Here, physical reactions can be replaced with “cognitive side effects/chemobrain”
  16. Brain plasticity refers to the brain ’s ability to change at any age (not just in childhood). Gray matter can grow or shrink. Neural connections can be forged, or severed. Forgetting a name reflects weakened wiring. Learning a new dance step strengthens a set of wiring.
  17. Growing out of the emerging recognition that brain function is far more distributed than localized, with each neuron broadly connected in networks, it uses a single sensor for each hemisphere (placed midway between the top of the ear and the crown of the head), and simultaneously analyzes the activity at eight clusters of frequencies ( “time-frequency envelopes”) in each hemisphere. The software does not reward the brain for movement toward a “normal” or “desired” pattern, but simply provides information to the brain—in the form of very brief subliminal interruptions in music the subject is hearing—whenever the brain shows signs of turbulence (indicated by phase state changes) in one or more of the 16 time-frequency envelopes. These brief interruptions trigger the orienting response in the brain, which—as a complex adaptive system—is able to self-organize in a way that avoids continued turbulence and moves to a more optimal dynamical pattern of flexibility and resilience. Interestingly, the concept of “turbulence,” as used in this software, is a mathematical concept, not an experiential one, so the client undergoing this form of neurofeedback is generally unaware of the brain activity triggering the feedback and the brain’s response.